Long COVID Fatigue May Be Down To A Protein That We Could Target With Drugs

Long COVID Fatigue May Be Down To A Protein That We Could Target With Drugs

Publication date: Jul 30, 2024

Image credit: Shuo YangAlthough this research was conducted in flies and mice, the team believes similar processes can happen in humans. IL-6 activates a biochemical pathway called JAK-STAT in muscles, and there are already a number of approved drugs that can block this pathway. In each of these diseases, the brain can be exposed to inflammatory proteins that lead to a buildup of reactive oxygen species. The ones on the left are from healthy muscles, while the ones on the right are from muscles exposed to IL-6.

Concepts Keywords
Alzheimers Advertisement
Biochemical Alzheimers
Mice Brain
Purple Covid
Viral Fatigue
Flies
Hope
Il
Infection
Inflammation
Johnson
Long
Muscle
Muscles
Symptoms

Semantics

Type Source Name
disease MESH muscle fatigue
disease MESH inflammation
disease MESH Long COVID
disease MESH syndromes
disease MESH complications
disease MESH infection
disease VO Bacteria
pathway REACTOME Immune System
disease IDO acute infection
disease MESH COVID-19
disease IDO process
drug DRUGBANK Tropicamide
disease MESH rheumatoid arthritis
pathway KEGG Rheumatoid arthritis
disease VO population

Original Article

(Visited 2 times, 1 visits today)